Market Cap
$958.67M
Shares Outstanding
73.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 10, 2020
Round Lot
100
Locale
US
Day Open
$13.30
Day High
$13.69
Day Low
$13.16
Volume
928.2K
VWAP
$13.46
Prev Close
$13.12
Transactions
--
Acc. Volume
--
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Cybin Inc. Common Stock (HELP) closed the 2026-09-16 session at $13.47, up 2.67% versus the previous close (+0.35). The stock opened at $13.30 and traded between $13.16 and $13.69 during that session. Session trading volume was 928K shares. The volume-weighted average price (VWAP) is $13.46.
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Cybin Inc. Common Stock has a market capitalization of $958.7 million. HELP is listed on the XNAS exchange. The company employs approximately 50 people. The recorded listing date is 2020-11-10.
On this page you can find market HELP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.